longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Trump Says US To Exempt Import Tariff On Generic Drugs For Two Years

rttnews
Jul 22, 2026 at 01:38 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

President Trump announced via Truth Social that generic drug imports into the U.S. will be exempt from tariffs for two years starting August 1, 2026. Following this period, a 100% tariff will apply for one year, increasing to 200% thereafter.

Add as your preferred news source on Google

Add Now

President Donald Trump has announced that he will exempt generic drugs imported into the U.S. from tariffs for two years.

This will come into effect on August 1. After that a 100 percent levy will be imposed on imported drugs, which will be increased to 200 percent a year later.

Trump made this announcement on Truth Social Tuesday.

"Effective August 1st, 2026, all Generic Drugs being brought into the United States will continue to have a TARIFF of ZERO PERCENT for a two year period of time, after which the TARIFF will be raised to 100% for a one year period of time, and 200% thereafter".

This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.

Start Free Trial

FREE 7-Day Trial - No Payment Required

Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Business News

Login to unlock442characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)
  • Apr 2, 2026 at 07:24 PMOfficial Announcement: US Maintains 50% Metal Tariffs, Imposes 25% Tariffs on Some Finished Products, 100% on Patented D…
  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 26, 2026 at 12:54 PMBeigene's Q4 revenue increased by 33% year-on-year, turning a profit for the full year, with Baiyueze achieving a record…
iShares US Pharma

iShares US Pharma

IHE.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI